John B. Sanfilippo & Son (JBSS) Misses Q4 EPS by 20c, Beats on Revenues
Get Alerts JBSS Hot Sheet
Price: $84.60 --0%
EPS Growth %: +13.0%
Financial Fact:
Total operating expenses: 19.92M
Today's EPS Names:
VAXX, EGRX, AFIB, More
EPS Growth %: +13.0%
Financial Fact:
Total operating expenses: 19.92M
Today's EPS Names:
VAXX, EGRX, AFIB, More
Join SI Premium – FREE
John B. Sanfilippo & Son (NASDAQ: JBSS) reported Q4 EPS of $0.59, $0.20 worse than the analyst estimate of $0.79. Revenue for the quarter came in at $201.59 million versus the consensus estimate of $191.14 million.
Quarterly Comparison Overview:
- Net sales decreased by 12.9%
- Sales volume decreased by 9.0%
- Gross profit margin increased by 220 basis points to 16.7%
- Net income decreased by 7.6%
For earnings history and earnings-related data on John B. Sanfilippo & Son (JBSS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Aebi Schmidt Holding AG (AEBI) Reports Q2 results; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share